HOPPER JONATHAN MARK (Chief Medical Officer) sold 13.1% of their position (10K shares) of VERICEL CORP on the open market
Open‑market sale worth $400.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/4/2025ACC: 0001140361-25-021415
Officer· Chief Medical Officer
Since Feb 2020
+10K
Net shares
Net buyer
$400.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$18.00
Trade value
$180K
% of position
15.1%
6/2/2025
66.24K→76.24K
Common Stock
Direct
Shares
−10K
Price / share
$40.09
Trade value
$400.90K
% of position
13.1%
6/2/2025
76.24K→66.24K
Total
Net shares
+0.00
Net value
-$220.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2025 | M · Option Exercise | +10K | $18.00 | $180K | 15.1% | 66.24K | 76.24K |
| Common Stock Direct | 6/2/2025 | S · Sale | −10K | $40.09 | $400.90K | 13.1% | 76.24K | 66.24K |
| Total | +0.00 | -$220.90K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10K shares
Shares
+10K
Strike price
18
Held after
18.75K
Exercisable
—
6/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10K shares | 6/2/2025 | M · Option Exercise | +10K | 18 | — | 18.75K |